HealthEquity - HQY Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings or view top-rated stocks.

11 Wall Street analysts have issued 12-month target prices for HealthEquity's stock. Their HQY share price forecasts range from $69.00 to $94.00. On average, they predict the company's share price to reach $81.25 in the next year. This suggests a possible upside of 45.0% from the stock's current price.
View analysts price targets for HQY or view top-rated stocks among Wall Street analysts.

HealthEquity's stock was trading at $61.64 at the beginning of 2023. Since then, HQY stock has decreased by 9.1% and is now trading at $56.02.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, June 5th 2023.
View our HQY earnings forecast.

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings data on Monday, December, 6th. The company reported $0.35 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.35. The firm had revenue of $180 million for the quarter, compared to analysts' expectations of $185.44 million. HealthEquity had a negative net margin of 3.03% and a positive trailing twelve-month return on equity of 3.51%. HealthEquity's revenue for the quarter was up .3% on a year-over-year basis. During the same period last year, the company earned $0.30 earnings per share.

ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), Putnam Sustainable Future ETF (PFUT), Global X FinTech ETF (FINX), SPDR S&P Health Care Services ETF (XHS), Nuveen Small Cap Select ETF (NSCS), iShares U.S. Healthcare Providers ETF (IHF), MFAM Small-Cap Growth ETF (MFMS) and ALPS Disruptive Technologies ETF (DTEC).

HealthEquity updated its FY 2024 earnings guidance on Wednesday, March, 22nd. The company provided earnings per share guidance of $1.74-$1.87 for the period, compared to the consensus EPS estimate of $1.77. The company issued revenue guidance of $960.00 million-$975.00 million, compared to the consensus revenue estimate of $961.58 million.

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

HealthEquity's stock is owned by a number of retail and institutional investors. Top institutional investors include William Blair Investment Management LLC (3.53%), JPMorgan Chase & Co. (2.53%), Brown Advisory Inc. (2.35%), Fred Alger Management LLC (1.87%), Geode Capital Management LLC (1.85%) and ArrowMark Colorado Holdings LLC (1.78%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HQY stock can currently be purchased for approximately $56.02.

HealthEquity (NASDAQ:HQY) has a market capitalization of $4.74 billion and generates $861.75 million in revenue each year. The company earns $-44,290,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis.

The company employs 3,695 workers across the globe.

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.